KRAS and metastatic neoplasm: NRAS mutation coexisted with KRAS wild-type (P<0.001), of note, codon61 mutation only appeared in KRAS wild-type tumors (P = 0.006), and codon12 and 13 had a significantly higher mutation rate in distant metastatic tumors (P = 0.016).